Patient-Reported Quality of Life and Convalescence After Minimally Invasive Kidney Cancer Surgery.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
10 2020
Historique:
received: 21 02 2020
revised: 25 05 2020
accepted: 15 06 2020
pubmed: 1 7 2020
medline: 4 2 2022
entrez: 1 7 2020
Statut: ppublish

Résumé

To better characterize recovery after minimally invasive kidney surgery, we present a study describing patient-reported health-related quality of life (HRQOL) following minimally invasive radical nephrectomy (RN) and partial nephrectomy (PN). Patients who underwent minimally invasive PN or RN for renal cancer were invited to enroll in a prospective, patient-reported HRQOL study using the Convalescence and Recovery Evaluation (CARE) instrument and Short Form-12. Patients completed questionnaires at baseline, 2, 4, 8, and 12 weeks after surgery. Mixed repeated measures model were used to assess time effect on HRQOL scores and predictors of scores within each surgery groups. One hundred seventy-seven patients were included in the study: 50 had RN and 127 had PN. At 2 weeks, both groups had significant decreases in Overall CARE, as well as the Pain, Gastrointestinal, and Activity domain scores which remained slightly below baseline at 4 weeks. At 4 weeks only 50% of patients in both the RN and PN cohorts returned to baseline overall CARE score. By 12 weeks 82% returned to baseline overall CARE score in the RN group while 76% of patients did so in the PN group. Convalescence after minimally invasive renal surgery can often extend beyond 4 weeks post-treatment in PN and RN subjects. This information may be used to provide more accurate preoperative counseling in an attempt to improve overall patient satisfaction.

Identifiants

pubmed: 32603743
pii: S0090-4295(20)30743-3
doi: 10.1016/j.urology.2020.06.020
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

123-129

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Adam B Althaus (AB)

Beth Israel Deaconess Medical Center, Division of Urology, Boston, MA.

Peter Chang (P)

Beth Israel Deaconess Medical Center, Division of Urology, Boston, MA.

Jialin Mao (J)

Weill Cornell Medical College; New York, NY.

Kola Olugbade (K)

Beth Israel Deaconess Medical Center, Division of Urology, Boston, MA.

Kimberly Taylor (K)

Beth Israel Deaconess Medical Center, Division of Urology, Boston, MA.

Lauren Dewey (L)

Beth Israel Deaconess Medical Center, Division of Urology, Boston, MA.

Andrew Percy (A)

Beth Israel Deaconess Medical Center, Division of Urology, Boston, MA.

Catrina Crociani (C)

Beth Israel Deaconess Medical Center, Division of Urology, Boston, MA.

Kyle McNally (K)

Beth Israel Deaconess Medical Center, Division of Urology, Boston, MA.

Andrew A Wagner (AA)

Beth Israel Deaconess Medical Center, Division of Urology, Boston, MA. Electronic address: awagner@bidmc.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH